Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The Collateral Vessel Activation Mechanism Perhaps the most distinctive cardiovascular property of BPC-157 is its ability to activate collateral blood vessel pathways
2 way Dual Activation GHRH-R (CJC-1295) + GHS-R1a (Ipamorelin) two complementary pituitary targets 2-4x GH AUC Demonstrated Synergy Area under the GH curve 2 to 4 times greater than each peptide in monotherapy 5.8 - 8.1 days CJC-1295 Half-Life Sustained elevation of IGF-1 for 9 to 11 days after a single injection 10 mg Pre-formulated mix 5 mg CJC-1295 (No DAC) + 5 mg Ipamorelin per vial | Purity 99% HPLC Selective Hormonal Profile Ipamorelin: no increase in cortisol, prolactin or ACTH (Raun et al., 1998) Mechanism of Action Dual-Channel Synergy Simultaneous activation of GHRH-R and GHS-R1a for amplified GH stimulation GHRH Lane CJC-1295 GHRH Analog (Mod GRF 1-29) A synthetic peptide of 29 amino acids that selectively binds to the GHRH receptor on pituitary somatotroph cells
A triple-peptide combination of BPC-157, TB-500, and GHK-Cu targeting complementary angiogenic, cellular migration, and extracellular matrix remodeling pathways in preclinical research
These quick, effective injections are tailored to support various health goals, including weight management, increased energy, enhanced immune function, and improved skin health
The peptides mechanism appears to preferentially mobilize fat from metabolically active depots while preserving muscle tissue, creating favorable body recomposition rather than non-selective weight loss
For people who want maximum simplicity, Retatrutide alone delivers extraordinary results
US$ 25.86
US$ 21.55
US$ 23.74
